Method. This is a prospective, randomized clinical trial. In 2008–2009, participants
were recruited from the oncology outpatient clinic of a medical center in Taiwan,
and were assigned to either the exercise group (n = 19) or the control group
(n = 21). Women in the exercise group participated in a moderate-intensity homebased
walking program for 12 weeks during their chemotherapy treatments.
Symptoms, mood status and physical activity level were measured at baseline,
6- and 12-week follow-up. Data were analysed by two-way repeated-measures
analysis of variance.